Prevalence of primary headaches in people with multiple sclerosis

Cephalalgia

Volumn 24, Issue 11, 2004, Pages 980-984

  D'Amico, Domenico ^a   La Mantia, L ^a   Rigamonti, A ^a   Usai, S ^a   Mascoli, N ^a   Milanese, C ^a   Bussone, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Headache; Interferon; International Headache Society criteria; Lifetime prevalence; Migraine

Indexed keywords

AZATHIOPRINE; COPOLYMER; IMMUNOMODULATING AGENT; INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLUSTER HEADACHE; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FISHER EXACT TEST; HEADACHE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PROSPECTIVE STUDY; TENSION HEADACHE;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 8144224052     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00790.x     Document Type: Article

References (31)

1. Abb L, Schaltebrand G. Statistische Untersuchungen zum Problem der multiplen Sklerose. II. Mitteilung das Krankheitsbild der multiplen Sklerose. Dtsh Z Nervenheilkd 1956; 174:199-218.
2. Bonduelle M, Albaranes R. Étude statistique de 145 case de sclérose en plaque. Semin Hop Paris 1962; 68:3762-73.
3. Poser CM, Presthus J, Horsda O. Clinical characteristics of autopsy-proved multiple sclerosis. Neurology 1966; 16:791-8.
4. Watkins MS, Espir M. Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatry 1969; 32:35-7.
5. Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol 1984; 41:1270-2.
6. Freedman MS, Gray TA. Vascular headache: a presenting symptom of multiple sclerosis. Can J Neurol Sci 1989; 16:63-6.
7. Rolak LA, Brown S. Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol 1990; 237:300-2.
8. Pollmann W, Erasmus LP, Feneberg W, Then Berg F, Straube A. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002; 59:636-9.
9. Adams DK, Sutherland JM, Fletcher WB. Early clinical manifestations of disseminated sclerosis. Br Med J 1950; 2:431-6.
10. McAlpine D, Compston ND. Some aspect of the natural history of disseminated sclerosis. Q J Med 1952; 21:135-67.
11. Kurtzke JF, Beebe GW, Nagler B, Auth TL, Kurland LT, Nefzger MD. Studies on natural history of multiple sclerosis. Acta Neurol Scand 1968; 44:467-94.
12. Brandes JL. Migraine induced by interferon beta therapy for multiple sclerosis. Neurology 2000; 54 (Suppl. 3):A422 (Abstract).
13. Headache Classification Committee of the IHS. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
14. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977; 33:4-9.
15. Kalman B, Lublin FD. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system. Curr Neurol Neurosci Rep 2001; 1:249-56.
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
17. Ad Hoc Committee of The National Institute of Neurological Disease and Blindness. Classification of headache. JAMA 1962; 179:173-6.
18. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R, Rice GP. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003; 361: 545-52.
19. Solari A, Radice D. Health status of people with multiple sclerosis: a community mail survey. Neurol Sci 2001; 22:307-15.
20. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population. Neurology 2000; 55:624-9.
21. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population sample of headache sufferers. Cephalalgia 1999; 19:107-14.
22. D'Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, Bussone G. Quality of life and disability in primary chronic daily headaches. Neurol Sci 2003; 24 (Suppl. 2):S97-100.
23. Oger J, Roos R, Antel JP. Immunology of multiple sclerosis. Neurol Clin 1983; 1:655-79.
24. Reder AT, Antel JP, Oger JJMC, Farland TA, Rosenkoetter M, Arnason BG. Low T8 antigen density on lymphocytes in active multiple sclerosis. Ann Neurol 1984; 16:242-9.
25. Leone M, Biffi M, Leoni F, Bussone G. Leukocytes subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache. Cephalalgia 1984; 14:139-42.
26. Nager BJ, Lanska DJ, Daroff RB. Acute demyelization mimicking vascular migraine. Headache 1989; 29:423-4.
27. Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993; 33:452-5.
28. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin 1990; 8:801-15.
29. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Diener HC. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1:658-60.
30. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaque-ductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001; 41:629-37.
31. Knight YE, Goadsby PJ. Periaqueductal grey matter modulates trigeminovascular input: a role in migraine. Neuroscience 2001; 106:793-800.